Compugen (XTAE:CGEN) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:CGEN Compugen Ltd XTAE:CGEN
43 GF Score
Price ₪7.25
! 4 Warning Signs
View Full Analysis

What is Compugen FFO?

FFO (Funds from operations) only applies to REITs.

XTAE:CGEN
43GF Score
Compugen Ltd XTAE:CGEN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Compugen Business Description

Other Exchanges CGEN:USA
Address 26 Harokmim Street, Building D, Azrieli Center, Holon, ISR, 5885849
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
43GF Score

Get the complete analysis for XTAE:CGEN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪7.25
Price